... — Centers for Disease Control and Prevention
...
... Referencias
Switch to Single-Tablet Bictegravir-Lenacapavir From a Complex HIV Regimen (Artistry-1): A Randomised, Open-Label, Phase 3 Clinical Trial — The Lancet
Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy — Gilead
...
... Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy — JAMA
Viral Suppression and HIV Transmission in Serodiscordant Male Couples: An International, Prospective, Observational, Cohort Study — The Lancet HIV
Swapping Daily Pills for Monthly Shots Could Transform HIV Treatment and Prevention ...
Cómo funcionan los medicamentos inyectables para tratar y prevenir el VIH
... Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy — JAMA
Viral Suppression and HIV Transmission in Serodiscordant Male Couples: An International, Prospective, Observational, Cohort Study — The Lancet HIV
Swapping Daily Pills for Monthly Shots Could Transform HIV Treatment and Prevention ...
... Department of Veterans Affairs
Expert Consensus Statement on the Science of HIV in the Context of Criminal Law — Journal of the International AIDS Society
VIH PrEP y PEP — MedlinePlus
HIV Infection: Risk Factors and Prevention Strategies — Wolters Kluwer UpToDate
HIV Viral Load — Cleveland Clinic
¿Cómo se transmite el VIH? ...
... Referencias
Early HIV Diagnosis and Treatment Important for Better Long-Term Health Outcomes — National Institutes of Health
Los síntomas del VIH — HIV.gov
Acute and Early HIV Infection: Clinical Manifestations and Diagnosis — Wolters Kluwer UpToDate
Síntomas iniciales del VIH: ¿qué son? ...
Dolor de garganta y VIH: ¿es un síntoma temprano?
... Referencias
Early HIV Diagnosis and Treatment Important for Better Long-Term Health Outcomes — National Institutes of Health
Los síntomas del VIH — HIV.gov
Acute and Early HIV Infection: Clinical Manifestations and Diagnosis — Wolters Kluwer UpToDate
Síntomas iniciales del VIH: ¿qué son? ...
... Considerations — HIV.gov
El VIH y la salud mental — HIVinfo.NIH.gov
10 Things To Know About HIV Suppression — National Institute of Allergy and Infectious Diseases
...
6 complicaciones del VIH que debe conocer
... Considerations — HIV.gov
El VIH y la salud mental — HIVinfo.NIH.gov
10 Things To Know About HIV Suppression — National Institute of Allergy and Infectious Diseases
...
... and Dyslipidemia Among HIV Infected Patients at Burayu Health Center, Addis Ababa, Ethiopia: A Cross-Sectional Comparative Study — BMC Research Notes
Drugs and Supplements Semaglutide (Subcutaneous Route) — Mayo Clinic
What’s the Secret Behind Ozempic’s Sweeping Health Benefits? ...
... Neuropharmacology
Potential Adverse Drug Events and Drug-Drug Interactions With Medical and Consumer Cannabidiol (CBD) Use — Journal of Clinical Medicine
The Effects of Cannabinoids on the Pharmacokinetics of Indinavir and Nelfinavir — AIDS
...
CBD para el VIH: ¿es eficaz?
... Neuropharmacology
Potential Adverse Drug Events and Drug-Drug Interactions With Medical and Consumer Cannabidiol (CBD) Use — Journal of Clinical Medicine
The Effects of Cannabinoids on the Pharmacokinetics of Indinavir and Nelfinavir — AIDS
...
... of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds — International Journal of Molecular Sciences
HIV Vaccines — HIV.gov
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010-2017 — Morbidity and Mortality Weekly Report
Treatment of HIV-2 Infection — Wolters Kluwer UpToDate ...
VIH-1 frente a VIH-2: ¿Cuáles son las diferencias y puede tener ambas?
... of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds — International Journal of Molecular Sciences
HIV Vaccines — HIV.gov
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010-2017 — Morbidity and Mortality Weekly Report
Treatment of HIV-2 Infection — Wolters Kluwer UpToDate ...